Furthermore, Mulder et al., showed that CCR2 has a crucial role in the recruitment of immune cells to white adipose tissue and the liver, and a CCR2 inhibitor, propagermanium, attenuated liver inflammation and NASH development (106). Here, CCR2 is linked to metabolic dysfunction-associated steatohepatitis.